Dyne Therapeutics Inc logo

Dyne Therapeutics Inc

NAS:DYN (USA)   Ordinary Shares
$ 26.83 +1.85 (+7.41%) 03:30 PM EST
At Loss
P/B:
10.07
Volume:
2.01M
Avg Vol (2M):
2.43M
Volume:
2.01M
At Loss
Avg Vol (2M):
2.43M

Business Description

Dyne Therapeutics Inc logo
Dyne Therapeutics Inc
NAICS : 541714 SIC : 2833
ISIN : US26818M1080

Share Class Description:

DYN: Ordinary Shares
Description
Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.
Name Current Vs Industry Vs History
Cash-To-Debt 5.59
Equity-to-Asset 0.74
Debt-to-Equity 0.19
Debt-to-EBITDA -0.13
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -42
3-Year EPS without NRI Growth Rate -40.7
3-Year FCF Growth Rate -42
Name Current Vs Industry Vs History
5-Day RSI 79.13
9-Day RSI 71.59
14-Day RSI 69.42
6-1 Month Momentum % 82.41
12-1 Month Momentum % 64.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.67
Quick Ratio 5.67
Cash Ratio 5.32

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -63.1
Shareholder Yield % -2.54
Name Current Vs Industry Vs History
ROE % -94.35
ROA % -77.01
ROIC % -487.46
ROC (Joel Greenblatt) % -579.18
ROCE % -87.36

Financials (Next Earnings Date:2024-03-01 Est.)

DYN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:DYN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Dyne Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.59
Beta 1.12
Volatility % 99.69
14-Day RSI 69.42
14-Day ATR ($) 1.465075
20-Day SMA ($) 22.9365
12-1 Month Momentum % 64.29
52-Week Range ($) 6.4 - 25.5
Shares Outstanding (Mil) 81.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Dyne Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Dyne Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Dyne Therapeutics Inc Frequently Asked Questions

What is Dyne Therapeutics Inc(DYN)'s stock price today?
The current price of DYN is $26.83. The 52 week high of DYN is $25.50 and 52 week low is $6.40.
When is next earnings date of Dyne Therapeutics Inc(DYN)?
The next earnings date of Dyne Therapeutics Inc(DYN) is 2024-03-01 Est..
Does Dyne Therapeutics Inc(DYN) pay dividends? If so, how much?
Dyne Therapeutics Inc(DYN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1